Is 2327.HK overvalued or undervalued?

2327.HK currently has a P/E ratio of 17.14. Relative to the sector average of 8.70, this suggests the stock may be overvalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

Can I buy fractional shares of 2327.HK?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 2327.HK protect my money against local inflation?

Many investors in Latin America buy international stocks like 2327.HK to protect their purchasing power. Because 2327.HK is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 2327.HK shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 2327.HK a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 2327.HK diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks2327.HK

Meilleure Health International Industry Group Limited

Q: How can I buy Meilleure Health International Industry Group Limited stock?

Meilleure Health International Industry Group Limited trades on HKSE. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

HK$0.22-HK$0.01-4.85%

HKSE / HKD

Market cap

HK$876M

P/E

17.1

EPS (TTM)

HK$0.00

Dividend yield

2.55%

Beta

0.03

1Y return

-28.00%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$32M2021

$15M2022

$17M2023

$7M2024

$5M2025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.22Low
Current ratio3.46
Cash ratio0.04
Net margin27.9%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

2327.HK17.1
Industrials sector median8.7
S&P 50022.0

Trades about 97% above its sector, the market expects faster growth.

Ratios

PEG0.55
Price to book0.67
EPS (TTM)HK$0.00
Payout ratio4,400%
FCF yield-4.70%

Range & risk

HK$0.20HK$0.30

Trading in the lower third of its 52-week band

Beta0.03

Profile

What Meilleure Health International Industry Group Limited actually does

Meilleure Health International Industry Group Limited functions as an investment holding company, overseeing a broad spectrum of ventures in Hong Kong, the People's Republic of China, and other international markets. Its diverse operations include industrial hemp, healthcare-related services, trading, various agency services, and both property investment/leasing and development. The company actively engages in the commerce of construction supplies, the creation and sale of residential real estate, property asset management, and the distribution of health-related goods. Furthermore, it provides real estate brokerage, services focused on the application of cannabidiol (CBD) derivatives, and comprehensive health management offerings, such as anti-aging treatments, aesthetic medicine, and general wellness consulting. It also acts as an agent for healthcare product sales. Formerly known as U-Home Group Holdings Limited, the company rebranded to Meilleure Health International Industry Group Limited in March 2017. Its primary corporate office is located in Admiralty, Hong Kong.

CEO

Wen Chuan Zhou

Employees

Headquarters

Hong Kong

Founded

2003-10-14

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 2327.HK and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

2327.HK has a beta of 0.03, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

Meilleure Health International Industry Group Limited